↓ Skip to main content

Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

policy
1 policy source
twitter
28 X users

Readers on

mendeley
161 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations
Published in
Journal for Immunotherapy of Cancer, September 2019
DOI 10.1186/s40425-019-0717-7
Pubmed ID
Authors

Amalia Anastasopoulou, Dimitrios C. Ziogas, Michael Samarkos, John M. Kirkwood, Helen Gogas

X Demographics

X Demographics

The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 161 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 12%
Student > Ph. D. Student 12 7%
Student > Bachelor 12 7%
Student > Master 11 7%
Student > Postgraduate 8 5%
Other 28 17%
Unknown 71 44%
Readers by discipline Count As %
Medicine and Dentistry 45 28%
Immunology and Microbiology 9 6%
Biochemistry, Genetics and Molecular Biology 8 5%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Unspecified 5 3%
Other 14 9%
Unknown 74 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2024.
All research outputs
#2,162,530
of 25,782,229 outputs
Outputs from Journal for Immunotherapy of Cancer
#578
of 3,517 outputs
Outputs of similar age
#43,154
of 351,695 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#16
of 75 outputs
Altmetric has tracked 25,782,229 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,517 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,695 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.